EpiVax H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Providence, RI HQ🌐 epivax.com
Does EpiVax sponsor H-1B visas?
Yes. EpiVax has filed 7 H-1B LCAs with the U.S. Department of Labor between FY2019 and FY2026. In FY2025 EpiVax filed 2 H-1B LCAs at a median base salary of $71,573. No PERM green-card cases are on record.
It files most often for Bioinformatics Analyst roles, most in Providence, RI.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2025 | 2 | $72k |
| FY2023 | 2 | $50k |
| FY2022 | 1 | $65k |
| FY2020 | 1 | $44k |
| FY2019 | 1 | $52k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Patents
- Granted
- 23
- US patents
- Published, not yet granted
- 40
- applications
- Most recent grant
- April 15, 2025
- Top area
- Specific therapeutic activity of chemical compounds13
Pay against the local market
EpiVax’s most-filed occupations and metros, FY2025. Its median base salary is 73% of the local BLS median for the same work.
| Occupation | Metro | Filings | EpiVax pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | Providence, RI | 2 | $71,573 | $98,590 | 73% |
About EpiVax
EpiVax is a pharma & biotech company based in Providence, RI. It was founded in 1998.
- Name (DOL filings)
- EpiVax, Inc.
- Listed
- Private
- Sponsoring since
- FY2019
- Headquarters
- Providence, United States
- Industry
- Pharma & biotech
- Founded
- 1998
- H-1B filings
- 7
- Median base
- $54,000
- Website
- epivax.com
H-1B sponsors similar to EpiVax
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Antares Pharma | 8 | 3 | $140k | 0 | — |
| Avidity Biosciences | 8 | 4 | $125k | 1 | — |
| Cellbae | 8 | 4 | $78k | 1 | — |
| EpiVax | 7 | 2 | $72k | 0 | — |
| Ardelyx | 7 | 3 | $125k | 0 | — |
| Affinia Therapeutics | 7 | 2 | $90k | 2 | — |
| Biodiscovery | 7 | 1 | $101k | 0 | — |
